Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers

Abstract

Background: Nanostructured lipid carriers (NLCs) are attractive materials for topical drug delivery, and in a previous study, we demonstrated that NLCs loaded with tripterine enhance its deposition. However, the surface charge of nanoparticles influences percutaneous drug penetration. Therefore, we aimed to evaluate the influence of the surface charge of NLCs on in vitro skin permeation and in vivo pharmacodynamics of tripterine and optimize tripterine-loaded NLCs for the treatment of skin diseases. Methods: Different solid and liquid matrices were selected to prepare cationic, anionic, and neutral NLCs by the solvent evaporation method. The in vitro studies were evaluated by using Franz diffusion cells. The effect of surface-charged NLCs on cellular uptake was appraised across HaCaT and B16BL6 cells. The in vitro and in vivo anticancer activity of surface-charged NLCs was evaluated in B16BL6 cells and melanoma-bearing mice, respectively. Results: The average particle sizes of the cationic, anionic, and neutral NLCs were 90.2 ± 9.7, 87.8 ± 7.4, and 84.5 ± 10.2 nm, respectively; their encapsulation efficiencies were 64.3% ± 5.1%, 67.8% ± 4.4%, and 72.5% ± 4.9%, respectively. In vitro studies showed delayed tripterine release, and the order of skin permeation was cationic NLCs . anionic NLCs . neutral NLCs. Further, in vitro cytotoxicity studies showed that the cationic NLCs had the highest (P , 0.05) inhibition ratio in B16BL6 (melanoma) cells. Moreover, in vivo pharmacodynamic experiments in melanoma-bearing mice indicated that the cationic NLCs had significantly higher (P , 0.05) antimelanoma efficacy than the anionic and neutral NLCs. Conclusion: The surface charge of NLCs has a great influence on the skin permeation and pharmacodynamics of tripterine. Cationic tripterine-loaded NLCs could enhance the percutaneous penetration and antimelanoma efficacy of tripterine and offer several advantages over tripterine alone. Therefore, they are promising carriers of tripterine for topical antimelanoma therapy.

Encapsulation of Oleuropein in Nanostructured Lipid Carriers: Biocompatibility and Antioxidant Efficacy in Lung Epithelial Cells

“…Nevertheless, all formulations displayed adequate sizes between 100 and 200 nm. Due to the dissociation of protons from the carboxylic groups of Precirol after dilution in deionized water (pH 5.6), NLCs exerted a negative superficial charge, which was found to be around −20 mV for all nanoformulations and thus all of them might have good physical stability [55,56]. In contrast, olive oil content significantly affected the freeze-drying process of the NLCs.…”

Transethosomal gels as carriers for the transdermal delivery of colchicine: statistical optimization, characterization, and ex vivo evaluation

“…The permeability coefficient (Kp, measured in cm/h) was calculated from the following equation: where Cd represents the drug concentration applied on the skin in the donor compartment. 28 …”

Dexmedetomidine and levobupivacaine co-loaded, transcriptional transactivator peptide modified nanostructured lipid carriers or lipid–polymer hybrid nanoparticles, which performed better for local anesthetic therapy?

“…In the present study, NLCs and LPNs showed a mean size of about 100 nm. NLCs are reported to have the abilities of biocompatibility, modified release kinetics which are suitable for topical drug delivery (Chen et al., 2012 ). LPNs are argued to have controlled release capability, high biocompatibility, and favorable pharmacokinetic profile, while may have an influence on the drug transdermal permeation (Zhang et al., 2015 ; Liu et al., 2018 ).…”